Among the established risk biomarkers, deleterious germline mutations in BRCA1/BRCA2/TP53 genes have been demonstrated as strong predictors of breast cancer development [2] and recent studies have also investigated the possible association between single nucleotide polymorphisms (SNPs) and breast cancer risk [3–5]. Here, TP53 is linked to breast cancer.